Various formulation technologies attempt to improve absorption, though clinical validation of enhanced bioavailability forms remains limited
The single-agent approach simplifies monitoring, reduces side effect management, and often proves sufficient for achieving clinical goals
When to contact your GP : Discuss GLP-1 treatment if you have type 2 diabetes with suboptimal control despite lifestyle changes and other medications, or if you're struggling with obesity-related health complications despite sustained efforts at dietary modification and increased physical activity
Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression
Pierret, Yuya Mizuno, Pippa Saunders, Eshaya Lim, Riccardo Dr Giorgi, Oliver Howes, Robert McCutcheon, Barbara McGowan, Piya Sen Gupta, Daniel Smith, Khalida Ismail, Toby Pillinger) was published in JAMA Psychiatry